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background: Despite advances in therapy, outcomes remain poor in patients with heart failure and reduced ejection fraction (HFrEF). Chronic 
baroreflex activation therapy (BAT) reduces sympathetic tone, increases baroreflex sensitivity and improves clinical variables in HFrEF patients. BAT 
improves survival in a rapid pacing model of heart failure. Long-term clinical effects on outcome are unknown.
Methods: Subjects enrolled in an open-label feasibility trial requiring NYHA Class III, LVEF ≤ 40%, optimal and stable medical therapy, no active 
treatment with cardiac resynchronization therapy and six-minute hall walk distance 150-450 m. Cumulative hospitalization use for worsening HFrEF 
was tracked over the year prior to implant and the year following BAT activation. Emergency department visits not requiring admission were counted 
as 1 day.
results: Eleven (10 Caucasian, 3 female) subjects were implanted, 8 completing 12 months of follow up and 3 completing 9 months. Medication 
remained stable. In the year before implant, 9 of the 11 patients accumulated 194 hospitalization days versus 27 days among 5 patients in the year 
after BAT activation. Average duration of stay for admissions decreased from 9.1 ± 5.1 to 6.5 ± 0.6 days (Mean ± SD, p=0.035).
conclusion: BAT is associated with substantially reduced hospital resource utilization for worsening HFrEF in this cohort. Prospective, randomized 
trials should validate this finding in a larger population. Studies are ongoing in Europe and North America.
